These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 30397585)

  • 1. Recent advances in improving oral drug bioavailability by cocrystals.
    Emami S; Siahi-Shadbad M; Adibkia K; Barzegar-Jalali M
    Bioimpacts; 2018; 8(4):305-320. PubMed ID: 30397585
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
    Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
    Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.
    Sathisaran I; Dalvi SV
    Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30065221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances on the Biological Study of Pharmaceutical Cocrystals.
    Wang Z; Xie Y; Yu M; Yang S; Lu Y; Du G
    AAPS PharmSciTech; 2022 Nov; 23(8):303. PubMed ID: 36396736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior.
    Kataoka M; Minami K; Takagi T; Amidon GE; Yamashita S
    Mol Pharm; 2021 Nov; 18(11):4122-4130. PubMed ID: 34618448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Aceclofenac-l-Cystine and Aceclofenac-Urea Cocrystals with Enhanced Oral Bioavailability.
    Kumar S; Gupta A; Mishra CK; Singh S
    Curr Drug Deliv; 2021; 18(8):1174-1181. PubMed ID: 33602085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion and Flux Improvement of Drugs through Complexation.
    Mannava MKC; Garai A; Nangia AK
    Mol Pharm; 2023 May; 20(5):2293-2316. PubMed ID: 36974968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical cocrystals and poorly soluble drugs.
    Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
    Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein.
    Pi J; Wang S; Li W; Kebebe D; Zhang Y; Zhang B; Qi D; Guo P; Li N; Liu Z
    Asian J Pharm Sci; 2019 Mar; 14(2):154-164. PubMed ID: 32104447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advancements in Pharmaceutical Cocrystals, Preparation Methods, and their Applications.
    Manchanda D; Kumar A; Nanda A
    Curr Pharm Des; 2021; 27(44):4477-4495. PubMed ID: 33858309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of Dissolution and Supersaturation/Precipitation of Poorly Water-Soluble Drugs from Cocrystals Based on Solubility Products: A Case Study with a Ketoconazole Cocrystal.
    Kataoka M; Yonehara A; Minami K; Takagi T; Yamashita S
    Mol Pharm; 2023 Aug; 20(8):4100-4107. PubMed ID: 37354097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocrystals Mitigate Negative Effects of High pH on Solubility and Dissolution of a Basic Drug.
    Chen YM; Rodríguez-Hornedo N
    Cryst Growth Des; 2018 Mar; 18(3):1358-1366. PubMed ID: 30505243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical Analysis and Optimization of Stoichiometric Ratio of Drug-Coformer on Cocrystal Design: Molecular Docking, In Vitro and In Vivo Assessment.
    Dhibar M; Chakraborty S; Basak S; Pattanayak P; Chatterjee T; Ghosh B; Raafat M; Abourehab MAS
    Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of a danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability.
    Childs SL; Kandi P; Lingireddy SR
    Mol Pharm; 2013 Aug; 10(8):3112-27. PubMed ID: 23822591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of Carbamazepine Cocrystals: Characterization,
    Wasim M; Mannan A; Asad MHHB; Amirzada MI; Shafique M; Hussain I
    Biomed Res Int; 2021; 2021():6685806. PubMed ID: 33816628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quabodepistat (OPC-167832), a Novel Antituberculosis Drug Candidate: Enhancing Oral Bioavailability via Cocrystallization and Mechanistic Analysis of Bioavailability in Two Cocrystals.
    Sakamoto N; Miyata K; Fukami T
    Mol Pharm; 2024 Jan; 21(1):358-369. PubMed ID: 38099729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the Solubility and Bioavailability of Progesterone Cocrystals with Selected Carboxylic Acids.
    Xiong J; Xu D; Zhang H; Shi Y; Wu X; Wang S
    Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems.
    Singh M; Barua H; Jyothi VGSS; Dhondale MR; Nambiar AG; Agrawal AK; Kumar P; Shastri NR; Kumar D
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuning the Pharmacokinetic Performance of Quercetin by Cocrystallization.
    Haskins MM; Kavanagh ON; Sanii R; Khorasani S; Chen JM; Zhang ZY; Dai XL; Ren BY; Lu TB; Zaworotko MJ
    Cryst Growth Des; 2023 Aug; 23(8):6059-6066. PubMed ID: 37547881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.